Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000950170-24-101430
Filing Date
2024-08-28
Accepted
2024-08-28 16:30:11
Documents
1
Period of Report
2024-08-06

Document Format Files

Seq Description Document Type Size
1 4/A ownership.html 4/A  
1 4/A ownership.xml 4/A 3220
  Complete submission text file 0000950170-24-101430.txt   4675
Mailing Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803
Business Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Issuer) CIK: 0001604950 (see all company filings)

EIN.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SCPHARMACEUITCALS, INC. 2400 DISTRICT AVENUE BURLINGTON MA 01803
Business Address
Nokes Rachael (Reporting) CIK: 0001769138 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38293 | Film No.: 241255899